-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, T6kgn+V2EwPWtCw2jjcL7sqMymICKswDRK3PNcscoa6Wd3oklKAWIUJ0qm3QCzkY wt25Yv2p16lIwBiXPHo9gQ== 0000874015-05-000008.txt : 20050104 0000874015-05-000008.hdr.sgml : 20050104 20050104175759 ACCESSION NUMBER: 0000874015-05-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050103 FILED AS OF DATE: 20050104 DATE AS OF CHANGE: 20050104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCNEIL JOHN A CENTRAL INDEX KEY: 0001181558 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 05509234 BUSINESS ADDRESS: STREET 1: 2292 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2292 FARADAY AVE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2292 FARADAY AVE CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-01-03 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001181558 MCNEIL JOHN A 2292 FARADAY AVENUE CARLSBAD CA 92008 0 1 0 0 Vice President Employee Stock Option (right to buy) 5.80 2005-01-03 2005-01-03 5 A 0 18158 0 A 2009-01-03 2012-01-02 Common Stock 18158 18158 D Grant of 1-3-05 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option will vest and become exercisable on 1-3-06. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 4,540 shares per year for the first two years, then 4,539 shares for the remaining two years. The option is exercisable as to 0 shares on 1-3-05. John A. McNeil 2005-01-04 -----END PRIVACY-ENHANCED MESSAGE-----